Literature DB >> 16414171

Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB.

Raffaella Ceccatelli1, Oliver Faass, Margret Schlumpf, Walter Lichtensteiger.   

Abstract

Considering the presence of polybrominated diphenylethers (PBDEs) in human milk and cord blood, and the estrogenic activity of some congeners, it is conceivable that PBDEs may interact with developing neuroendocrine systems. We investigated effects of 2,2',4,4',5-pentabromo-DE (PBDE 99), a major congener in human milk, on development of brain and reproductive organs, with focus on estrogen target gene expression. Time-pregnant Long Evans rats were subcutaneously injected with PBDE 99 (1 or 10 mg/kg/day), the PCB mixture Aroclor 1254 (10 mg/kg/day), known to interfere with sexual development, or vehicle, from gestational day (GD) 10 to GD 18. In female offspring, anogenital distance was unaffected by PBDE 99 but increased by Aroclor; puberty (vaginal opening) was not significantly changed. Adult PBDE 99-exposed offspring exhibited unchanged uterine weight but increased ovarian weight. Uterine mRNA levels of estrogen target genes were determined by real-time PCR. Progesterone receptor (PR) mRNA was down-regulated at both PBDE 99 doses, estrogen receptor alpha (ER alpha), ER beta and insulin-like growth factor-I (IGF-I) were up-regulated at the lower dose. Aroclor induced different effect patterns. In order to investigate possible changes in sensitivity of target genes to estrogen, some offspring were ovariectomized at 10 weeks of age, s.c. injected with estradiol-17beta (E2, 10 microg/kg) or vehicle at 12 weeks, and sacrificed 6 h later. PBDE 99 dose-dependently reduced the magnitude of IGF-I mRNA induction by E2, and increased the magnitude of ER beta repression. PBDE 99 also influenced baseline levels of PR, IGF-I and ER beta mRNAs in ovariectomized, vehicle-injected controls. These data indicate that developmental exposure to PBDE 99 at doses devoid of general toxicity, affects the regulation of estrogen target genes in uterus. Since PBDE 99 was detected in blood and adipose tissue of adult offspring, these effects may result from interactions with developmental processes, adult functions, or a combination of both.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414171     DOI: 10.1016/j.tox.2005.12.004

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  33 in total

Review 1.  Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.

Authors:  Sarah M Dickerson; Andrea C Gore
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

2.  Perinatal exposure to low-dose DE-71 increases serum thyroid hormones and gonadal osteopontin gene expression.

Authors:  Charles A Blake; George L McCoy; Yvonne Y Hui; Holly A LaVoie
Journal:  Exp Biol Med (Maywood)       Date:  2011-03-02

3.  Polybrominated diphenyl ethers disrupt molting in neonatal Daphnia magna.

Authors:  Rebecca Davies; Enmin Zou
Journal:  Ecotoxicology       Date:  2012-04-03       Impact factor: 2.823

4.  Toxic effects of maternal zearalenone exposure on uterine capacity and fetal development in gestation rats.

Authors:  Yuanyuan Zhang; Zhiqiang Jia; Shutong Yin; Anshan Shan; Rui Gao; Zhe Qu; Min Liu; Shaoping Nie
Journal:  Reprod Sci       Date:  2013-12-19       Impact factor: 3.060

Review 5.  Endocrine-disrupting chemicals: economic, regulatory, and policy implications.

Authors:  Christopher D Kassotis; Laura N Vandenberg; Barbara A Demeneix; Miquel Porta; Remy Slama; Leonardo Trasande
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08       Impact factor: 32.069

Review 6.  Regulation of estrogen receptor beta activity and implications in health and disease.

Authors:  Elin Swedenborg; Krista A Power; Wen Cai; Ingemar Pongratz; Joëlle Rüegg
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

7.  Polybrominated diphenyl ether (PBDE) neurotoxicity: a systematic review and meta-analysis of animal evidence.

Authors:  David C Dorman; Weihsueh Chiu; Barbara F Hales; Russ Hauser; Kamin J Johnson; Ellen Mantus; Susan Martel; Karen A Robinson; Andrew A Rooney; Ruthann Rudel; Sheela Sathyanarayana; Susan L Schantz; Katrina M Waters
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2018-10-23       Impact factor: 6.393

8.  Effects of fluoro substitution on 4-bromodiphenyl ether (PBDE 3).

Authors:  J Klösener; D C Swenson; L W Robertson; G Luthe
Journal:  Acta Crystallogr B       Date:  2008-01-17

9.  Receptor interactions by polybrominated diphenyl ethers versus polychlorinated biphenyls: a theoretical Structure-activity assessment.

Authors:  G Luthe; J A Jacobus; L W Robertson
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

10.  Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats.

Authors:  Dongren Yang; Kyung Ho Kim; Andrew Phimister; Adam D Bachstetter; Thomas R Ward; Robert W Stackman; Ronald F Mervis; Amy B Wisniewski; Sabra L Klein; Prasada Rao S Kodavanti; Kim A Anderson; Gary Wayman; Isaac N Pessah; Pamela J Lein
Journal:  Environ Health Perspect       Date:  2008-09-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.